DOCSLIB.ORG

Containing Truncated Mutant Proteins in the Tumors with High Microsatellite Instability

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Containing Truncated Mutant Proteins in the Tumors with High Microsatellite Instability Published OnlineFirst May 14, 2013; DOI: 10.1158/1078-0432.CCR-13-0684 Clinical Cancer Human Cancer Biology Research Identification and Selective Degradation of Neopeptide- Containing Truncated Mutant Proteins in the Tumors with High Microsatellite Instability Won Kyu Kim1, Misun Park1, Minhee Park1, Yun Ji Kim1, Nara Shin1, Hyun Ki Kim1, Kwon Tae You2, and Hoguen Kim1 Abstract Purpose: Frameshift mutations in coding mononucleotide repeats (cMNR) are common in tumors with high microsatellite instability (MSI-H). These mutations generate mRNAs containing abnormal coding sequences and premature termination codons (PTC). Normally, mRNAs containing PTCs are degraded by nonsense-mediated mRNA decay (NMD). However, mRNAs containing PTCs located in the last exon are not subject to degradation by NMD (NMD-irrelevant). This study aimed to discover whether genes with frameshift mutations in the last exon generate truncated mutant proteins. Experimental Design: We identified 66 genes containing cMNRs in the last exon by bioinformatic analysis. We found frequent insertion/deletion mutations in the cMNRs of 29 genes in 10 MSI-H cancer cell lines and in the cMNRs of 3 genes in 19 MSI-H cancer tissues. We selected 7 genes (TTK, TCF7L2, MARCKS, ASTE1, INO80E, CYHR1, and EBPL) for mutant mRNA expression analysis and 3 genes (TTK, TCF7L2, and MARCKS) for mutant protein expression analysis. Results: The PTC-containing NMD-irrelevant mRNAs from mutated genes were not degraded. However, only faint amounts of endogenous mutant TTK and TCF7L2 were detected, and we failed to detect endogenous mutant MARCKS. By polysome analysis, we showed that mRNAs from genomic mutant MARCKS constructs are normally translated. After inhibiting 3 protein degradation pathways, we found that only inhibition of the proteasomal pathway facilitated the rescue of endogenous mutant TTK, TCF7L2, and MARCKS. Conclusions: Our findings indicate that cancer cells scavenge potentially harmful neopeptide-containing mutant proteins derived from NMD-irrelevant abnormal mRNAs via the ubiquitin–proteasome system, and these mutant proteins may be important substrates for tumor-specific antigens. Clin Cancer Res; 19(13); 3369–82. Ó2013 AACR. Introduction tions inactivate genes by introducing premature termina- Activating mutations in oncogenes and inactivating tion codons (PTC) in mRNA. If mRNAs bearing PTCs are mutations in tumor suppressor genes are hallmarks of not degraded and allowed to be translated normally, then human cancers (1). The common inactivation pathways of genes with nonsense mutations are expected to generate tumor suppressor genes are deletion of one allele and truncated proteins lacking neopeptides, whereas genes with inactivating mutations of the other allele (2). Of these frameshift mutations are expected to generate truncated pathways, nonsense and frameshift mutations are the most proteins containing neopeptides. Generally, most abnor- critical inactivating mutations (3). These 2 types of muta- mal PTC-containing mRNAs are actively degraded by nonsense-mediated mRNA decay (NMD), thus avoiding the potentially deleterious effects associated with the Authors' Affiliations: 1Department of Pathology and Brain Korea 21 production of truncated proteins (4, 5). NMD is mediated Projects for Medical Science, Yonsei University College of Medicine; and through the recognition of PTC-containing mRNAs, 2School of Biological Science and Center for National Creative Research, Seoul National University, Seoul, Republic of Korea which are recognized by their position relative to the last exon–exon junction. Mammalian transcripts that contain Note: Supplementary data for this article are available at Clinical Cancer Research Online (http://clincancerres.aacrjournals.org/). PTCs more than 50 to 55 nucleotides (nt) upstream of the last exon–exon junction are degraded by NMD, which Corresponding Author: Hoguen Kim, Yonsei University College of Med- icine, 134 Shinchon-Dong Seodaemun-Gu, Seoul 120-752, Republic of ensures the degradation of most PTC-containing mRNAs. Korea. Phone: 82-2-2228-1761; Fax: 82-2-363-5263; E-mail: However, PTCs located within 50 to 55 nt or downstream [email protected] of the last exon–exon junction are not recognized by doi: 10.1158/1078-0432.CCR-13-0684 NMD and can potentially lead to the generation of Ó2013 American Association for Cancer Research. mutant proteins (6, 7). www.aacrjournals.org 3369 Downloaded from clincancerres.aacrjournals.org on September 28, 2021. © 2013 American Association for Cancer Research. Published OnlineFirst May 14, 2013; DOI: 10.1158/1078-0432.CCR-13-0684 Kim et al. National Research Resource Bank Program of the Korea Translational Relevance Science and Engineering Foundation of the Ministry of Abnormal mRNAs containing premature termina- Science and Technology. Authorization for the use of the tion codon (PTC) derived from frameshift mutation tissues for research was obtained from the Institutional in the last exon are not subject to degradation by Review Board. Conventional pathologic parameters were the nonsense-mediated mRNA decay (NMD) system. examined without prior knowledge of the molecular data These NMD-irrelevant mRNAs are expected to generate (Table 1). neopeptide-containing truncated mutant proteins. We identified mutant genes containing PTC derived from Identification of MSI and mutation analysis the last exon in colon cancers with high microsatellite Genomic DNA and cDNA preparation, analysis of MSI, instability. We showed that the NMD-irrelevant mutant and identification of target gene mutations were conducted mRNAs from the identified genes are normally trans- using a PCR-based assay as described previously (16). lated, but the neopeptide-containing truncated mutant proteins are selectively degraded by the ubiquitin– Semiquantitative RT-PCR and qRT-PCR proteasome system. Our results indicate that mutant The primers for semiquantitative reverse transcription proteins generated from NMD-irrelevant mRNAs can (RT)-PCR and quantitative reverse transcription PCR contribute to the formation of tumor-specific antigens (qRT-PCR) were designed using Primer 3 database and these antigens can be used as specific targets for (http://frodo.wi.mit.edu/primer3/). All RNAs were isolated immunotherapy. from cells using TRIzol (Invitrogen). Reverse transcription was conducted using M-MLV reverse transcriptase (Invitro- gen). For RT-PCR, the reaction was conducted using Ampli- Taq Gold 360 DNA Polymerase (Applied Biosystems). For A subset of colorectal tumors exhibits length alterations qRT-PCR, the reaction was conducted using the ABI PRISM in several coding and noncoding microsatellites, a molec- 7500 Sequence Detector (Applied Biosystems) and SYBR ular phenotype termed high microsatellite instability (MSI- Premix Ex Taq II (TaKaRa). The amount of target mRNA was H; refs. 8, 9). The length alterations in microsatellites of the normalized to that of GAPDH or EGFP mRNA [derived from coding region [coding mononucleotide repeats (cMNRs)] the enhanced GFP (EGFP)-expressing control vector]. The result in frameshift mutations in the affected genes, and sequences of the primers used are listed in Supplementary these mutations are believed to contribute to tumor devel- Table S1. opment and progression (10). Although many reports indicated that numerous genes are frequently mutated in Construction of TTK, TCF7L2, and MARCKS expression their cMNRs in MSI-H cancers, few of these genes have been vectors, RNAi, and transfection reported to express their mutant gene products in MSI-H cDNA expression vectors for TTK [cTTK(WT)], TCF7L2 cancers (11–13). We searched for genes containing cMNRs [cTCF4L2(WT)], and MARCKS [cMARCKS(WT)] were con- in the last exon and analyzed the frequency of mutations in structed by cloning the respective wild-type (WT) genes into these genes. We addressed whether genes with frameshift pcDNA3.1 vectors containing a FLAG tag via amplification mutations generate truncated mutant proteins. We showed of their coding regions using the cDNAs derived from HeLa that mutant proteins are actively translated from genes and WiDr cells. For the genomic DNA form of the MARCKS containing mutations in cMNRs in the last exon but are expression vector [gMARCKS(WT)], all exons and introns rarely detected because these endogenous truncated pro- between the exons of MARCKS were cloned into pcDNA3.1 teins containing neopeptides are extensively degraded by vectors containing a FLAG tag. To generate mutant protein the ubiquitin–proteasome system. expression vectors for TTK [cTTK(À2)], TCF7L2 [cTCF7L2 (À1)], and MARCKS [cMARCKS(À2), gMARCKS(À2)], Materials and Methods deletion mutagenesis was conducted. All transfection Tissue samples and cell lines experiments were carried out using Lipofectamine 2000 For the mutation analysis, 12 cell lines were used. DLD1, (Invitrogen), and a CMV10-EGFP vector was used to con- HCT116, HCT-8, LOVO, LS174T, RKO, SNUC2A, SNUC2B, firm the transfection efficiency. The primers used for cloning SNUC4, and SNU407 cells are MSI-H colorectal carcinoma are listed in Supplementary Table S1. The siRNAs against cell lines, whereas WiDr and HeLa cells are microsatellite- TTK, TCF7L2, and MARCKS used in this study (Bioneer) stable (MSS) cell lines, as determined by previous studies were also transfected into cells using Lipofectamine. (14, 15). Cells were grown in RPMI, minimum essential medium, and Dulbecco’s modified Eagle medium supple- Western blotting and mutant protein-specific antibody mented with 10% FBS (Life Technologies),
Load more

Recommended publications
  • Exam 1 Name Mcbio
    Exam 1 Name _______________________________ Mcbio 316 Q1. Mutants defective for the proofreading function of DNA polymerase III typically form small, unhealthy looking colonies on rich medium. (2) Why? • Such mutations in the dnaQ gene (called mutD) produce a "mutator" phenotype. Because they are unable to proofread errors that occur during DNA replication, such strains accumulate mutations at a high frequency. The resulting large number of "lethal mutations" that arise during cell division slows the growth of the colonies. • The mutation frequency is highest when the cells are growing on rich medium which allows the cells to grow more rapidly than the resulting errors can be corrected by other repair systems. Q2. The DNA and corresponding amino acid sequence of a portion of the wild-type trpA gene is shown below. The DNA sequence of three different trpA mutations is shown directly below the corresponding region in the wild-type sequence. [The DNA sequence of the coding strand is shown -- i.e., TTG = UUG => Leu.] 209 210 211 212 213 214 215 216 217 218 219 220 221 TTG CAG GGA TTT GGT ATT TCC GCC CCG GAT CAG GTA AAA Leu Gln Gly Phe Gly Ile Ser Ala Pro Asp Gln Val Lys * TAG CAG GGA TTT GGT ATT TCC GCC CCG GAT CAG GTA AAA Amber * TTG CAG GGA TTT GGT GTT TCC GCC CCG GAT CAG GTA AAA Leu Gln Gly Phe Gly Val Ser Ala Pro Asp Gln Val Lys D TTG CAG GGA TTT GGT ATT TCC GCC CCG ATC AGG TAA AA- Leu Gln Gly Phe Gly Ile Ser Ala Pro Ile Arg Ochre (6) Using the attached codon table, show the amino acid sequence for the protein made in each of the three trpA mutants.
    [Show full text]
  • Molecular Modelling and Screening of Androgen Receptor Ligands to Treat Prostate Cancer
    MOLECULAR MODELLING AND SCREENING OF ANDROGEN RECEPTOR LIGANDS TO TREAT PROSTATE CANCER A THESIS Submitted to The Tamil Nadu Dr.MGR Medical University, Chennai In the partial fulfillment of the requirements for the award of the degree of DOCTOR OF PHILOSOPHY In Faculty of Pharmacy & Pharmaceutical Sciences By S. DIVAKAR, M. Pharm., (Reg. No. 141340505) Under the guidance of Dr. M. RAMANATHAN, M.Pharm., Ph.D. Professor and Head Department of Pharmacology PSG College of Pharmacy Coimbatore June 2017 Dr. M. RAMANATHAN, M.Pharm., PhD., Professor and Head, Department of Pharmacology, PSG College of Pharmacy, Coimbatore. Certificate This is to certify that the Ph.D. thesis entitled “MOLECULAR MODELLING AND SCREENING OF ANDROGEN RECEPTOR LIGANDS TO TREAT PROSTATE CANCER” being submitted to the Tamil Nadu Dr. MGR Medical University, Chennai, for the award of degree of DOCTOR OF PHILOSOPHY in PHARMACY & PHARMACEUTICAL SCIENCES was carried out by S. DIVAKAR at PSG College of Pharmacy, Peelamedu, Coimbatore, under my direct supervision and guidance to my fullest satisfaction. The contents of this thesis, in full or in parts, have not been submitted to any other Institute or University for the award of any degree or diploma. Dr. M. RAMANATHAN, M.Pharm., Ph.D. (Supervisor & Guide) Place:Coimbatore Date: Dr. V. Sankar, M. Pharm, PhD., Professor and Head, Department of Pharmaceutics, PSG College of Pharmacy, Coimbatore. Certificate This is to certify that the Ph.D. thesis entitled “MOLECULAR MODELLING AND SCREENING OF ANDROGEN RECEPTOR LIGANDS TO TREAT PROSTATE CANCER” being submitted to the Tamil Nadu Dr. MGR Medical University, Chennai, for the award of degree of DOCTOR OF PHILOSOPHY in PHARMACY & PHARMACEUTICAL SCIENCES was carried out by S.
    [Show full text]
  • Analysis of P53 Mutations and Their Expression in 56 Colorectal Cancer Cell Lines
    Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines Ying Liu and Walter F. Bodmer* Cancer Research UK Cancer and Immunogenetics Laboratory, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom Contributed by Walter F. Bodmer, November 23, 2005 A comprehensive analysis of the TP53 gene and its protein status thought to mark the transition from adenoma to carcinoma, than in was carried out on a panel of 56 colorectal cancer cell lines. This early adenomas. This finding implies that most TP53 mutations analysis was based on a combination of denaturing HPLC mutation probably occur before metastasis (7, 8). The mechanism of how, or screening of all exons of the p53 gene, sequencing the cDNA, and whether, p53 plays a role in the metastasis of CRC remains assessing the function of the p53 protein by assaying the induced unknown. In an effort to address the above questions, we have expression of phosphorylated p53 and p21 after exposing cells to carried out a thorough analysis of p53 status in a panel of 56 ␥-rays. In a few cases where there was no production of p53 genetically well characterized CRC cell lines. The implications of message nor evidence of functional p53 protein, all of the p53 the results and comparisons with published data are discussed. exons were sequenced directly. Thirteen of the 56 cell lines had functional p53, 21 lines had missense mutations (one of which Results made no detectable protein), 4 lines produced no p53 transcripts, TP53 Mutation Detection. Primers located at least 50 bp away from and the remaining 18 lines carried truncating TP53 mutations.
    [Show full text]
  • Computational and Experimental Approaches to Reveal the Effects of Single Nucleotide Polymorphisms with Respect to Disease Diagnostics
    Int. J. Mol. Sci. 2014, 15, 9670-9717; doi:10.3390/ijms15069670 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Review Computational and Experimental Approaches to Reveal the Effects of Single Nucleotide Polymorphisms with Respect to Disease Diagnostics Tugba G. Kucukkal 1,†, Ye Yang 2,†, Susan C. Chapman 3,*, Weiguo Cao 2,* and Emil Alexov 1,* 1 Department of Physics, Clemson University, Clemson, SC 29634, USA; E-Mail: [email protected] 2 Department of Genetics and Biochemistry, Clemson University, 049 Life Sciences Facility, 190 Collins Street, Clemson, SC 29634, USA; E-Mail: [email protected] 3 Department of Biological Sciences, Clemson University, Clemson, SC 29634, USA † These authors contributed equally to this work. * Authors to whom correspondence should be addressed; E-Mails: [email protected] (S.C.C.); [email protected] (W.C.); [email protected] (E.A.); Tel.: +1-864-656-5307 (E.A.); Fax: +1-864-656-0805 (E.A.). Received: 8 April 2014; in revised form: 15 May 2014 / Accepted: 16 May 2014 / Published: 30 May 2014 Abstract: DNA mutations are the cause of many human diseases and they are the reason for natural differences among individuals by affecting the structure, function, interactions, and other properties of DNA and expressed proteins. The ability to predict whether a given mutation is disease-causing or harmless is of great importance for the early detection of patients with a high risk of developing a particular disease and would pave the way for personalized medicine and diagnostics. Here we review existing methods and techniques to study and predict the effects of DNA mutations from three different perspectives: in silico, in vitro and in vivo.
    [Show full text]
  • IGA 8/E Chapter 14
    16 Mutation, Repair, and Recombination WORKING WITH THE FIGURES 1. In Figure 16-3a, what is the consequence of the new 5′ splice site on the open reading frame? In 16-3b, how big could the intron be to maintain the reading frame (let’s say between 75 and 100 bp)? Answer: A mutation that generates a new 5′ splice site within an existing exon will result in the loss of information from the open reading frame, since some of the exon will be removed with the splicing of the intron. In addition, because the number of nucleotides deleted is not a multiple of 3 (64 nt) a frameshift mutation will result. In part b of the figure, the retained intron will maintain the reading frame as long as the length in nucleotides is divisible by three (ex. 99 bp) and it does not contain any stop codons in the same frame as exon 1. 2. Using Figure 16-4 as an example, compare the migration of RNA and protein for the wild-type gene and the mutation shown in Figure 16-3b. Assume that the retained intron maintains the reading frame. Answer: The RNA produced by the mutation in Figure 16-3b will be longer than the mature wild-type RNA and thus will not migrate as far in the gel. The same will be true of the protein (mutant protein will be larger than wild-type protein) if the reading frame is maintained and no stop codons are present in the sequence. 3. In the Ames test shown in Figure 16-17, what is the reason for adding the liver extract to each sample? Answer: Sometimes compounds only become mutagenic when processed by the enzymes in the vertebrate liver.
    [Show full text]
  • In Silico Analysis Predicting Effects of Deleterious Snps of Human
    www.nature.com/scientificreports OPEN In silico analysis predicting efects of deleterious SNPs of human RASSF5 gene on its structure and functions Md. Shahadat Hossain1,3, Arpita Singha Roy1 & Md. Sajedul Islam 2,3* Ras association domain-containing protein 5 (RASSF5), one of the prospective biomarkers for tumors, generally plays a crucial role as a tumor suppressor. As deleterious efects can result from functional diferences through SNPs, we sought to analyze the most deleterious SNPs of RASSF5 as well as predict the structural changes associated with the mutants that hamper the normal protein–protein interactions. We adopted both sequence and structure based approaches to analyze the SNPs of RASSF5 protein. We also analyzed the putative post translational modifcation sites as well as the altered protein–protein interactions that encompass various cascades of signals. Out of all the SNPs obtained from the NCBI database, only 25 were considered as highly deleterious by six in silico SNP prediction tools. Among them, upon analyzing the efect of these nsSNPs on the stability of the protein, we found 17 SNPs that decrease the stability. Signifcant deviation in the energy minimization score was observed in P350R, F321L, and R277W. Besides this, docking analysis confrmed that P350R, A319V, F321L, and R277W reduce the binding afnity of the protein with H-Ras, where P350R shows the most remarkable deviation. Protein–protein interaction analysis revealed that RASSF5 acts as a hub connecting two clusters consisting of 18 proteins and alteration in the RASSF5 may lead to disassociation of several signal cascades. Thus, based on these analyses, our study suggests that the reported functional SNPs may serve as potential targets for diferent proteomic studies, diagnosis and therapeutic interventions.
    [Show full text]
  • IN SILICO MODELING the EFFECT of SINGLE POINT MUTATIONS and RESCUING the EFFECT by SMALL MOLECULES BINDING Zhe Zhang Clemson University, [email protected]
    Clemson University TigerPrints All Dissertations Dissertations 5-2013 IN SILICO MODELING THE EFFECT OF SINGLE POINT MUTATIONS AND RESCUING THE EFFECT BY SMALL MOLECULES BINDING Zhe Zhang Clemson University, [email protected] Follow this and additional works at: https://tigerprints.clemson.edu/all_dissertations Part of the Biological and Chemical Physics Commons Recommended Citation Zhang, Zhe, "IN SILICO MODELING THE EFFECT OF SINGLE POINT MUTATIONS AND RESCUING THE EFFECT BY SMALL MOLECULES BINDING" (2013). All Dissertations. 1126. https://tigerprints.clemson.edu/all_dissertations/1126 This Dissertation is brought to you for free and open access by the Dissertations at TigerPrints. It has been accepted for inclusion in All Dissertations by an authorized administrator of TigerPrints. For more information, please contact [email protected]. IN SILICO MODELING THE EFFECT OF SINGLE POINT MUTATIONS AND RESCUING THE EFFECT BY SMALL MOLECULES BINDING A Thesis Presented to the Graduate School of Clemson University In Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy Physics and Astronomy by Zhe Zhang May 2013 Accepted by: Dr. Emil Alexov, Committee Chair Dr. Feng Ding Dr. Sumanta Tewari Dr. Charles Schwartz Dr. Maria Miteva Dr. Philippe Roche ABSTRACT Single-point mutation in genome, for example, single-nucleotide polymorphism (SNP) or rare genetic mutation, is the change of a single nucleotide for another in the genome sequence. Some of them will result in an amino acid substitution in the corresponding protein sequence (missense mutations); others will not. This investigation focuses on genetic mutations resulting in a change in the amino acid sequence of the corresponding protein. This choice is motivated by the fact that missense mutations are frequently found to affect the native function of proteins by altering their structure, interaction and other properties and cause diseases.
    [Show full text]
  • A Low-Prevalence Single-Nucleotide Polymorphism in the Sensor Kinase Phor in Mycobacterium Tuberculosis Suppresses Its Autophosp
    fmicb-12-724482 August 19, 2021 Time: 16:39 # 1 ORIGINAL RESEARCH published: 25 August 2021 doi: 10.3389/fmicb.2021.724482 A Low-Prevalence Single-Nucleotide Polymorphism in the Sensor Kinase PhoR in Mycobacterium tuberculosis Suppresses Its Autophosphatase Activity and Reduces Pathogenic Fitness: Implications in Evolutionary Selection Uchenna Watson Waturuocha1,2, M. S. Krishna1, Vandana Malhotra3, Narendra M. Dixit4,5 and Deepak Kumar Saini2,5* 1 Department of Studies in Zoology, University of Mysore, Mysore, India, 2 Department of Molecular Reproduction Development and Genetics, Indian Institute of Science, Bengaluru, India, 3 Sri Venkateswara College, University of Delhi, New Delhi, India, 4 Department of Chemical Engineering, Indian Institute of Science, Bengaluru, India, 5 Center Edited by: for Biosystems Science and Engineering, Indian Institute of Science, Bengaluru, India George Grant, University of Aberdeen, United Kingdom The genome sequencing of Mycobacterium tuberculosis, the causative organism of Reviewed by: tuberculosis, has significantly improved our understanding of the mechanisms that Amanda Jane Gibson, Aberystwyth University, drive the establishment of infection and disease progression. Several clinical strains United Kingdom of M. tuberculosis exhibit single-nucleotide polymorphisms (SNPs), the implications Roberto Zenteno-Cuevas, of which are only beginning to be understood. Here, we examined the impact of Universidad Veracruzana, Mexico a specific polymorphism in PhoR, the sensor kinase of the PhoPR two-component *Correspondence: Deepak Kumar Saini system. Biochemical analysis revealed reduced autophosphatase/ATPase activity, which [email protected] led to enhanced downstream gene expression. We complemented M. tuberculosis H37Ra with the wild-type and mutant phoPR genes and characterized the strains in Specialty section: This article was submitted to a cell line infection model.
    [Show full text]
  • Impaired NEPHRIN Localization in Kidney Organoids Derived from Nephrotic Patient Ips Cells
    www.nature.com/scientificreports OPEN Impaired NEPHRIN localization in kidney organoids derived from nephrotic patient iPS cells Tomoko Ohmori1, Shankhajit De1, Shunsuke Tanigawa1, Koichiro Miike1, Mazharul Islam1, Minami Soga2, Takumi Era2, Shinichi Shiona3, Koichi Nakanishi4,5, Hitoshi Nakazato6 & Ryuichi Nishinakamura1* Mutations in the NPHS1 gene, which encodes NEPHRIN, cause congenital nephrotic syndrome, resulting from impaired slit diaphragm (SD) formation in glomerular podocytes. We previously reported NEPHRIN and SD abnormalities in the podocytes of kidney organoids generated from patient-derived induced pluripotent stem cells (iPSCs) with an NPHS1 missense mutation (E725D). However, the mechanisms underlying the disease may vary depending on the mutations involved, and thus generation of iPSCs from multiple patients is warranted. Here we established iPSCs from two additional patients with diferent NPHS1 mutations and examined the podocyte abnormalities in kidney organoids derived from these cells. One patient had truncating mutations, and NEPHRIN was undetectable in the resulting organoids. The other patient had a missense mutation (R460Q), and the mutant NEPHRIN in the organoids failed to accumulate on the podocyte surface to form SD precursors. However, the same mutant protein behaved normally when overexpressed in heterologous cells, suggesting that NEPHRIN localization is cell context-dependent. The localization of another SD-associated protein, PODOCIN, was impaired in both types of mutant organoids in a cell domain-specifc manner. Thus, the new iPSC lines and resultant kidney organoids will be useful resources for dissecting the disease mechanisms, as well as for drug development for therapies. Te glomerulus is the fltration apparatus within the kidney, and the podocytes in glomeruli are essential for the fltration process1,2.
    [Show full text]
  • Analysis and Interpretation of the Impact of Missense Variants in Cancer
    International Journal of Molecular Sciences Review Analysis and Interpretation of the Impact of Missense Variants in Cancer Maria Petrosino 1, Leonore Novak 1, Alessandra Pasquo 2, Roberta Chiaraluce 1 , Paola Turina 3 , Emidio Capriotti 3,* and Valerio Consalvi 1,* 1 Dipartimento Scienze Biochimiche “A. Rossi Fanelli”, Sapienza University of Rome, 00185 Roma, Italy; [email protected] (M.P.); [email protected] (L.N.); [email protected] (R.C.) 2 ENEA CR Frascati, Diagnostics and Metrology Laboratory FSN-TECFIS-DIM, 00044 Frascati, Italy; [email protected] 3 Dipartimento di Farmacia e Biotecnologie (FaBiT), University of Bologna, 40126 Bologna, Italy; [email protected] * Correspondence: [email protected] (E.C.); [email protected] (V.C.) Abstract: Large scale genome sequencing allowed the identification of a massive number of genetic variations, whose impact on human health is still unknown. In this review we analyze, by an in silico-based strategy, the impact of missense variants on cancer-related genes, whose effect on protein stability and function was experimentally determined. We collected a set of 164 variants from 11 proteins to analyze the impact of missense mutations at structural and functional levels, and to assess the performance of state-of-the-art methods (FoldX and Meta-SNP) for predicting protein stability change and pathogenicity. The result of our analysis shows that a combination of experimental data on protein stability and in silico pathogenicity predictions allowed the identification of a subset of variants with a high probability of having a deleterious phenotypic effect, as confirmed by the Citation: Petrosino, M.; Novak, L.; significant enrichment of the subset in variants annotated in the COSMIC database as putative cancer- Pasquo, A.; Chiaraluce, R.; Turina, P.; driving variants.
    [Show full text]
  • The Effects of Single Nucleotide Polymorphisms in Cancer Rnai
    cancers Review The Effects of Single Nucleotide Polymorphisms in Cancer RNAi Therapies 1, 1, 1 2 Magdalena Gebert y, Maciej Ja´skiewicz y , Adrianna Moszy ´nska , James F. Collawn and Rafał Bartoszewski 1,* 1 Department of Biology and Pharmaceutical Botany, Medical University of Gda´nsk,80-416 Gda´nsk,Poland; [email protected] (M.G.); [email protected] (M.J.); [email protected] (A.M.) 2 Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA; [email protected] * Correspondence: [email protected] These authors contributed equally to this work. y Received: 21 September 2020; Accepted: 23 October 2020; Published: 25 October 2020 Simple Summary: Despite the recent progress in RNAi delivery of siRNA-based therapeutics for cancer therapy, the presence of single nucleotide polymorphisms (SNPs) in the general population could dramatically reduce the effectiveness of RNAi therapy. Their ubiquitous presence can also lead to unpredictable and adverse side effects. Because both SNPs and somatic mosaicisms have also been implicated in a number of human diseases including cancer, however, these specific changes offer the ability to selectively and efficiently target cancer cells. Here, we discuss how SNPs influence the development and success of novel anticancer RNAi therapies. Abstract: Tremendous progress in RNAi delivery methods and design has allowed for the effective development of siRNA-based therapeutics that are currently under clinical investigation for various cancer treatments. This approach has the potential to revolutionize cancer therapy by providing the ability to specifically downregulate or upregulate the mRNA of any protein of interest.
    [Show full text]
  • 1 Characterization of the P.Q189X Nonsense Mutation in Dpy-17 in C. Elegans By: Alyssa Li Wellesley College, Department of Biolo
    Characterization of the p.Q189X nonsense mutation in dpy-17 in C. elegans By: Alyssa Li Wellesley College, Department of Biological Sciences Abstract The need to characterize the genetic basis for phenotypes in Caenorhabditis elegans arises from its astonishingly high homology to humans and other eukaryotic organisms. In particular, aspects of the dpy genes’ structure and function, which encodes a flexible and resilient exoskeleton (i.e., cuticle collagen) crucial for normal body morphology in C. elegans, can be applied to other organisms. We report the location and characterization of a functionally significant dpy gene mutation in C. elegans. The dpy gene of interest was determined to be located on chromosome 3 and linked to unc-32 via linkage testing. The dpy gene was found to be 14.7 map units (m.u.) from unc-32 via mapping. Complementation analysis indicated that the gene of interest was dpy-17, a previously characterized gene. The mutant dpy-17 gene was sequenced and analyzed to understand the effects of the mutation at the nucleotide and amino acid level. The nature and extent of the change in the dpy-17 gene in the mutant vs. wild type (WT) C. elegans was determined to be a nonsense mutation via PCR and Sanger sequencing, resulting in an early stop codon in the mutant. The WT polypeptide sequence is nearly twice as long as the mutant peptide, as predicted by DNAstar. Our work in studying the molecular consequences of mutations in dpy-17 in C. elegans is extremely valuable, as it provides insight into the gene’s significant relevance to Marfan syndrome in humans and may inform new and effective treatments in the future.
    [Show full text]